Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-09-30 Purchase |
2024-10-02 08:00 am |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
23,836 | $0.47442 | $11,308 | 214,349 (Indirect Direct) |
View |
2024-05-28 Purchase(A) |
2024-07-31 4:09 pm |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
15,000 | $0.5183 | $7,775 | 3,165,712 (Indirect Direct) |
View |
2024-05-21 Purchase(A) |
2024-07-31 4:08 pm |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
50,000 | $0.6095 | $30,475 | 3,150,712 (Indirect Direct) |
View |
2024-05-10 Purchase(A) |
2024-07-31 4:07 pm |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
40,000 | $0.47163 | $18,865 | 3,100,712 (Indirect Direct) |
View |
2024-05-07 Purchase(A) |
2024-07-31 4:07 pm |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
66,300 | $0.3743 | $24,816 | 3,060,712 (Indirect Direct) |
View |
2024-05-06 Purchase(A) |
2024-07-31 4:06 pm |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
135,000 | $0.3753 | $50,666 | 2,994,412 (Indirect Direct) |
View |
2024-04-19 Purchase(A) |
2024-07-31 4:06 pm |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
15,000 | $0.5199 | $7,799 | 2,859,412 (Indirect Direct) |
View |
2024-04-17 Purchase(A) |
2024-07-31 4:05 pm |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
245,072 | $0.53622 | $131,411 | 2,844,412 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-01 Option Award |
2025-01-03 5:36 pm |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
120,000 | $0 | 334,349 (Direct) |
View |
2024-05-28 Option Award |
2024-06-03 09:00 am |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
15,000 | $0.5183 | 3,165,712 (Direct) |
View |
2024-05-22 Option Award |
2024-05-23 06:00 am |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
25,000 | $0.64 | 3,150,712 (Direct) |
View |
2024-05-21 Option Award |
2024-05-23 06:00 am |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
25,000 | $0.579 | 3,150,712 (Direct) |
View |
2024-05-10 Option Award |
2024-05-14 07:53 am |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
20,000 | $0.465 | 3,100,712 (Direct) |
View |
2024-05-11 Option Award |
2024-05-14 07:53 am |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
10,000 | $0.4665 | 3,100,712 (Direct) |
View |
2024-05-13 Option Award |
2024-05-14 07:53 am |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
10,000 | $0.49 | 3,100,712 (Direct) |
View |
2024-05-07 Option Award |
2024-05-07 7:41 pm |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
66,300 | $0.3743 | 3,060,712 (Direct) |
View |
2024-05-06 Option Award |
2024-05-07 09:14 am |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
135,000 | $0.3753 | 2,994,412 (Direct) |
View |
2024-04-19 Option Award |
2024-04-25 4:01 pm |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
15,000 | $0.5199 | 2,859,412 (Direct) |
View |
2024-04-17 Option Award |
2024-04-19 06:05 am |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
130,000 | $0.5457 | 2,844,412 (Direct) |
View |
2024-04-18 Option Award |
2024-04-19 06:05 am |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
115,072 | $0.5255 | 2,844,412 (Direct) |
View |
2024-03-11 Option Award |
2024-03-13 8:54 pm |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
305,198 | $0 | 2,599,340 (Direct) |
View |
2023-08-02 Option Award |
2023-08-04 4:05 pm |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & CEO |
31,185 | $0 | 2,294,142 (Direct) |
View |
2023-04-20 Option Award |
2023-04-24 06:44 am |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim President & Co-CEO |
75,000 | $0 | 2,262,957 (Direct) |
View |
2022-09-18 Option Award |
2023-01-04 07:35 am |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim Chief Executive Officer |
31,185 | $0 | 2,187,957 (Direct) |
View |
2021-12-10 Option Award |
2021-12-10 8:04 pm |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim Chief Executive Officer |
31,185 | $0 | 2,156,772 (Direct) |
View |
2020-07-26 Option Award |
2020-07-31 5:10 pm |
N/A N/A |
BRAINSTORM CELL THERAPEUTICS INC. | BCLI | Lebovits Chaim Chief Executive Officer |
31,185 | $0 | 2,125,587 (Direct) |
View |